Related Experiment Videos
Case study: Fatal strongyloidiasis associated with human T-cell lymphotropic virus type 1 infection
A O Adedayo1, G A Grell, P Bellot
1Department of Medicine, Princess Margaret Hospital, Roseau, Dominica. oadedayo@hotmail.com
The American Journal of Tropical Medicine and Hygiene
|November 22, 2001
Summary
A fatal case of strongyloidiasis in a patient with human T-cell lymphotropic virus type 1 (HTLV-1) highlights the risks of hyperinfection. Repeated stool exams are crucial for HTLV-1 positive individuals in endemic areas.
Area of Science:
- Medical Parasitology
- Infectious Diseases
- Immunology
Background:
- Human T-cell lymphotropic virus type 1 (HTLV-1) infection is endemic in many tropical and subtropical regions.
- Strongyloidiasis, caused by the nematode Strongyloides stercoralis, is also prevalent in these areas.
- HTLV-1 infection can impair cell-mediated immunity, potentially increasing susceptibility to opportunistic infections like strongyloidiasis.
Observation:
- A case report details a 45-year-old West Indian man with a history of HTLV-1 infection presenting with severe gastrointestinal symptoms.
- Clinical signs included intense diarrhea, vomiting, and significant weight loss.
- Microscopic examination of stool samples confirmed the presence of Strongyloides stercoralis larvae.
Findings:
- Despite treatment with thiabendazole, a standard antihelmintic, the patient experienced a fatal outcome.
- Autopsy revealed extensive ileocolitis caused by Strongyloides larvae, a subdiaphragmatic abscess, and severe pleuritis.
- This indicates a hyperinfective state of Strongyloides stercoralis, leading to disseminated disease.
Implications:
- Mortality remains high in patients with Strongyloides hyperinfection syndrome, even with appropriate antihelmintic therapy.
- For individuals in or from areas endemic for both HTLV-1 and strongyloidiasis, particularly those positive for HTLV-1, repeated stool microscopy is essential for early diagnosis.
- This case underscores the importance of considering co-infections and their synergistic impact on disease severity and outcomes.